510(k) K061005

ACCUSTEP DOA SINGLE AND MULTI-STRIP SCREEN PANELS by Applied Dna Technologies, Inc. — Product Code DKZ

K061005 is an FDA 510(k) premarket notification submitted by Applied Dna Technologies, Inc. for the device "ACCUSTEP DOA SINGLE AND MULTI-STRIP SCREEN PANELS". The FDA issued a decision of Substantially Equivalent on October 4, 2006. The device falls under product code DKZ (Enzyme Immunoassay, Amphetamine), a Class II device regulated under 21 CFR 862.3100. Applied Dna Technologies, Inc. has at least 3 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 4, 2006
Date Received
April 11, 2006
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Immunoassay, Amphetamine
Device Class
Class II
Regulation Number
862.3100
Review Panel
TX
Submission Type